All Type of News
KFDA to review possible approval of new chemical drugs with novel salts
The Korea Food and Drug Administration said recently it is now considering allowing the approval of new chemical drugs with novel salts in re-examination period after consultation with legal advisors, saying that newl...
KOSDAQ-listed pharmaceutical firms' sales rise 12.4%
The 15 KOSDAQ-listed pharmaceutical manufacturing firms marketed combined sales of 347.2 billion won in the first nine months of this year, an increase of 12.4 percent due to brisk sales of generic or new drug...
KSE-listed pharmaceutical firms showing strong 3-quarter results
KSE (Korea Stock Exchange)-listed pharmaceutical firms in the first nine months of this year continued to post robust sales of 2.4 trillion won, up 14.5 percent compared with 2.1 trillion won from a year earlier, acco...
Negotiation on next year NHI reimbursement prices failed.
The NHI reimbursement price negotiation between the medical/pharmacy communities and the NHIC was failed due to too distant views and interests.
The NHIC and Medical Insurance Expense Council (MIEC) negotiated on t...
Target marketing on OTC drugs at pharmacy.
Pharmacists are trying to increase OTC drugs sales by so called a target marketing strategy in an attempt to overcome the recent economy recession.
The target marketing focused on a certain class of consumers or sp...
Hanmi Pharm wins US patent for amlodipine camsylate
Hanmi Pharm said it has acquired an U.S. patent for the manufacturing process of amlodipine camsylate with better combination of properties in terms of photo stability and purity, soon after the obtainment of the Kore...
Insertion of measurement device in child's liquid forms to be made compulsory
The Regulatory Reform Committee said that its revised regulation governing the compulsory use in child-resistant container/package of liquid forms and insertion of measurement device in container will go into effect f...
Two foreign vaccine firms faces penalty for false ads
The Korea Food and Drug Administration said on November 11 that it is considering taking administrative measures to deal with two foreign-invested pharmaceutical firms, GlaxoSmithKline (GSK) and Sanofi-Aventis Korea, ...
Novartis saying no more exclusive distributions.
In the brief meeting with 15 associated drug wholesalers out of the total 50 at 4 p.m. on Nov. 11 at Hilton hotel, Novartis made it clear not to keep an exclusive distribution policy with any wholesalers in the future...
Drug distribution informations may cut off irregularities.
In the Korea Independent Commission Against Corruption (KICAC) meeting led by President Roh Moo-hyun at Cheongwhatae on Nov. 9, Minister Kim Keun-tae of MOHW said that any negative practices such as drug trade rebates...
